(1)
Kara, M.; Alp, G.; Cinakli, H. Real-World Outcomes of Baricitinib Monotherapy Versus CsDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy, Safety, and Drug Retention. Archives of Rheumatology 2025, 40, 279-287.